TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B

被引：0

作者：

Hsu, Yao-Chun ^{[1
]}

Wong, Grace Lai-Hung ^{[2
,3
]}

Chen, Chien Hung ^{[4
]}

Peng, Cheng-Yuan ^{[5
]}

Yeh, Ming-Lun ^{[6
]}

Cheung, Ka-Shing ^{[7
]}

Toyoda, Hidenori ^{[8
]}

Huang, Chung-Feng ^{[9
]}

Trinh, Huy N. ^{[10
]}

Xie, Qing ^{[11
]}

Enomoto, Masaru ^{[12
]}

Liu, Li ^{[13
]}

Yasuda, Satoshi ^{[8
]}

Tanaka, Yasuhito ^{[14
,15
]}

Kozuka, Ritsuzo ^{[12
]}

Tsai, Pei-Chien ^{[6
]}

Huang, Yen-Tsung ^{[16
]}

Wong, Christopher ^{[17
]}

Huang, Rui ^{[18
]}

Jang, Tyng-Yuan ^{[19
]}

Hoang, Joseph ^{[20
]}

Yang, Hwai-I ^{[21
]}

Li, Jiayi ^{[22
]}

Lee, Dong Hyun ^{[23
]}

Takahashi, Hirokazu ^{[24
]}

Zhang, Jianqing ^{[25
]}

Ogawa, Eiichi ^{[26
]}

Zhao, Changqing ^{[27
]}

Liu, Chenghai ^{[28
]}

Furusyo, Norihiro ^{[26
]}

Eguchi, Yuichiro ^{[29
]}

Wong, Clifford ^{[17
]}

Wu, Chao ^{[18
]}

Kumada, Takashi ^{[30
]}

Yuen, Man-Fung ^{[31
]}

Yu, Ming-Lung ^{[6
]}

Nguyen, Mindie H. ^{[20
]}

机构：

[1] I Shou Univ, Kaohsiung, Taiwan

[2] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] China Med Univ, Sch Med, Taichung, Taiwan

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Queen Mary Hosp, Med, Hong Kong, Peoples R China

[8] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan

[9] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[10] San Jose Gastroenterol, San Jose, CA USA

[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China

[12] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[13] Third Hosp Kumming City, Kunming, Yunnan, Peoples R China

[14] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[15] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[16] Acad Sinica, Taipei, Taiwan

[17] Wong Clin, Singapore, Singapore

[18] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China

[19] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[20] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[21] Acad Sinica, Genom Res Ctr, Taipei, Taiwan

[22] Palo Alto Med Fdn, Mt View Div, Palo Alto, CA USA

[23] Good Gang An Hosp, Busan, South Korea

[24] Saga Univ, Fac Med, Div Endocrinol & Metab, Saga, Japan

[25] Chinese Hosp, Beijing, Peoples R China

[26] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Fukuoka, Japan

[27] Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[28] Shanghai Univ TCM, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[29] Saga Med Sch, Fac Med, Dept Internal Med, Saga, Japan

[30] Ogaki Municipal Hosp, Ogaki, Gifu, Japan

[31] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

459

引用

页码：290A / 291A

页数：2

共 50 条

[1] Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Hsu, Yao-Chun
Wong, Grace Lai-Hung
Chen, Chong
Peng, Cheng-Yuan
Yeh, Ming-Lun
Cheung, Ka-Shing
Toyoda, Hidenori
Huang, Chung-Feng
Huy Trinh
Xie, Qing
Enomoto, Masaru
Liu, Li
Yasuda, Satoshi
Tanaka, Yasuhito
Kozuka, Ritsuzo
Tsai, Pei-Chien
Huang, Yen-Tsung
Wong, Christopher
Huang, Rui
Jang, Tyng-Yuan
Hoang, Joseph
Yang, Hwai-, I
Li, Jiayi
Lee, Dong-Hyun
Takahashi, Hirokazu
Zhang, Jian Q.
Ogawa, Eiichi
Zhao, Changqing
Liu, Chenghai
Furusyo, Norihiro
Eguchi, Yuichiro
Wong, Clifford
Wu, Chao
Kumada, Takashi
Yuen, Man-Fung
Yu, Ming-Lung
Nguyen, Mindie H.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02): : 271 - 280
[2] Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
Kamal, Faisal
Khan, Muhammad Ali
Ahmed, Aijaz
Nair, Satheesh
GUT, 2020, 69 (11) : 2054 - +
[3] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
Choi, Won-Mook
Choi, Jonggi
Wong, Grace Lai-Hung
Han, Seungbong
Lim, Young-Suk
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
[4] Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Lee, Sung Won
Choi, Jonggi
Kim, Seung Up
Lim, Young-Suk
CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 402 - 412
[5] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?
Yuan, Bao-Hong
Zhu, Yan-Kun
Li, Ru-Hong
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 314 - 315
[6] Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
Facciorusso, Antonio
Cincione, Ivan
Sacco, Rodolfo
LIVER CANCER, 2021, 10 (03) : 285 - 286
[7] Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naive Chronic Hepatitis B Patients in Korea
Choi, HeeKyoung
Seo, Gi Hyeon
JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 10
[8] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis
Huang, Rui
Liu, Jiacheng
Wang, Jian
Wu, Chao
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1040 - 1041
[9] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply
Yip, Terry C. -F.
Wong, Grace L. -H.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 315 - 316
[10] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
van Velsen, Lisa M.
Sonneveld, Milan J.
van Erpecum, Karel J.
HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922

← 1 2 3 4 5 →